首页 > 最新文献

Revista de neurologia最新文献

英文 中文
[Occupational performance skills in Parkinson's disease: relationship with health-related quality of life and caregiver burden. Letter]. [帕金森病患者的职业表现技能:与健康相关生活质量和护理负担的关系。信]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-16 DOI: 10.33588/rn.7712.2023314
A N Geldres-Palomino, M I Y Poma-Barrientos
{"title":"[Occupational performance skills in Parkinson's disease: relationship with health-related quality of life and caregiver burden. Letter].","authors":"A N Geldres-Palomino, M I Y Poma-Barrientos","doi":"10.33588/rn.7712.2023314","DOIUrl":"10.33588/rn.7712.2023314","url":null,"abstract":"","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 12","pages":"305"},"PeriodicalIF":0.8,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical profile and non-recreational methamphetamine abuse (shabu) among stroke patients in the Philippine population]. [菲律宾人口中中风病人的临床概况和非娱乐性甲基苯丙胺(shabu)滥用情况]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-16 DOI: 10.33588/rn.7712.2023238
A Rodríguez-Campello, G Figueras-Aguirre, V Puchades, A Ois-Santiago, E Cuadrado-Godia, E Giralt-Steinhauer, J Jiménez-Conde, B Bertran-Recasens, I Fernández-Pérez, C Soriano-Tárraga, J A Mateus, J Roquer

Introduction: Chronic non-recreational use of methamphetamine (shabu) is increasing among the Filipino population in Barcelona. The Asian population presents a different stroke pattern, with a higher incidence of haemorrhage, and different vascular risk factors and health behaviours. The objective of this study is to describe the stroke profile and incidence of methamphetamine use in patients of Filipino origin admitted to our centre.

Patients and methods: Demographic data, vascular risk factors, clinical data and prognosis were recorded. Methamphetamine exposure was analysed in plasma samples collected on admission, which were then analysed by liquid chromatography-mass spectrometry.

Results: Of a total of 6,418 stroke patients, 73 (1.1%) were identified as being of Filipino origin. The mean age was 54.4 ± 12.1 years, 54% were male and the stroke was ischaemic in 64.4% of cases. Arterial hypertension was the main risk factor. Ten (13.7%) patients tested positive for methamphetamine and amphetamine. These results confirm recent substance use prior to the stroke, mostly in men (80%). In patients who were consumers, 60% had a haemorrhagic stroke, with a poor functional prognosis at three months in 55.6% of patients.

Conclusions: In our setting, patients of Filipino ethnicity admitted for stroke related to the consumption of shabu belonged a younger age bracket, with a lower prevalence of vascular risk factors and a predominance of the haemorrhagic subtype. Methamphetamine testing in Filipino stroke patients is recommended due to the high prevalence of methamphetamine use in our country.

导言:在巴塞罗那的菲律宾人口中,长期非娱乐性吸食甲基苯丙胺(shabu)的现象日益增多。亚洲人的中风模式不同,出血发生率较高,血管风险因素和健康行为也不同。本研究的目的是描述本中心收治的菲律宾裔患者的中风概况和使用甲基苯丙胺的发生率:记录人口统计学数据、血管风险因素、临床数据和预后。在入院时采集的血浆样本中分析甲基苯丙胺的暴露情况,然后用液相色谱-质谱法进行分析:结果:在 6418 名中风患者中,有 73 人(1.1%)被确认为菲律宾裔。平均年龄为 54.4 ± 12.1 岁,54% 为男性,64.4% 的中风患者为缺血性中风。动脉高血压是主要的风险因素。10名患者(13.7%)的甲基苯丙胺和苯丙胺检测呈阳性。这些结果证实了患者在中风前近期服用过药物,其中男性居多(80%)。在服用药物的患者中,60%为出血性中风,55.6%的患者在三个月后功能预后较差:在我们的病例中,因吸食鸦片而中风的菲律宾裔患者年龄较轻,血管风险因素发生率较低,出血性亚型中风占多数。由于在我国甲基苯丙胺的使用率很高,建议对菲律宾籍中风患者进行甲基苯丙胺检测。
{"title":"[Clinical profile and non-recreational methamphetamine abuse (shabu) among stroke patients in the Philippine population].","authors":"A Rodríguez-Campello, G Figueras-Aguirre, V Puchades, A Ois-Santiago, E Cuadrado-Godia, E Giralt-Steinhauer, J Jiménez-Conde, B Bertran-Recasens, I Fernández-Pérez, C Soriano-Tárraga, J A Mateus, J Roquer","doi":"10.33588/rn.7712.2023238","DOIUrl":"10.33588/rn.7712.2023238","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic non-recreational use of methamphetamine (shabu) is increasing among the Filipino population in Barcelona. The Asian population presents a different stroke pattern, with a higher incidence of haemorrhage, and different vascular risk factors and health behaviours. The objective of this study is to describe the stroke profile and incidence of methamphetamine use in patients of Filipino origin admitted to our centre.</p><p><strong>Patients and methods: </strong>Demographic data, vascular risk factors, clinical data and prognosis were recorded. Methamphetamine exposure was analysed in plasma samples collected on admission, which were then analysed by liquid chromatography-mass spectrometry.</p><p><strong>Results: </strong>Of a total of 6,418 stroke patients, 73 (1.1%) were identified as being of Filipino origin. The mean age was 54.4 ± 12.1 years, 54% were male and the stroke was ischaemic in 64.4% of cases. Arterial hypertension was the main risk factor. Ten (13.7%) patients tested positive for methamphetamine and amphetamine. These results confirm recent substance use prior to the stroke, mostly in men (80%). In patients who were consumers, 60% had a haemorrhagic stroke, with a poor functional prognosis at three months in 55.6% of patients.</p><p><strong>Conclusions: </strong>In our setting, patients of Filipino ethnicity admitted for stroke related to the consumption of shabu belonged a younger age bracket, with a lower prevalence of vascular risk factors and a predominance of the haemorrhagic subtype. Methamphetamine testing in Filipino stroke patients is recommended due to the high prevalence of methamphetamine use in our country.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 12","pages":"293-298"},"PeriodicalIF":0.8,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Review of a series of cases of Creutzfeldt-Jakob disease in a tertiary care hospital]. [一家三级医院克雅氏病系列病例回顾]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-16 DOI: 10.33588/rn.7712.2023257
D Villagrán-Sancho, F J Gómez-Fernández, A C Luque-Ambrosiani, F J Hernández-Chamorro, E Franco-Macías, M Bernal-Sánchez Arjona

Introduction: We analysed a series of patients with sporadic Creutzfeldt-Jakob disease in our setting.

Aim: The aim of this study is to describe the characteristics of our sample using the new diagnostic tools based on the most recently published criteria.

Material and methods: A descriptive, retrospective study was conducted using a digitalised hospital register. We identified 20 cases of the sporadic type, in the period 2012-2022: eight with a pathological diagnosis and 12 with high probability. The variables sex, age at onset, time of evolution, clinical phenotype, magnetic resonance imaging (MRI) findings, 14.3.3 protein, electroencephalogram (EEG), real-time quaking-induced prion protein conversion (RT-QuIC), autopsy, pathological phenotype and genetic diagnosis were recorded.

Results: Of those affected, 50% were men and 50%, women, with an age at onset of 67 years (30-83) and a mean survival time of eight months (1-11 months). Cognitive impairment was the most frequent onset symptom, followed by gait ataxia. All MRI scans with long time-lapse sequences (FLAIR and DWI) were pathological, and the pattern of diffuse cortical and basal ganglia involvement was the most frequent. Altogether, 55% of the sample had an EEG with characteristic triphasic complexes. Sixty-five per cent were positive for 14.3.3 protein in cerebrospinal fluid. Four RT QuIC studies were carried out (in 2020) and all were positive. In 40% of them a confirmatory autopsy was performed, with the MM/MV1 pattern being the most frequent.

Conclusions: MRI with DWI sequences is a particularly sensitive test for the diagnosis of the disease, although its sensitivity decreases in the early stages. The high specificity and sensitivity of RT-QuIC, together with a characteristic clinical diagnosis and radiological pattern, are proposed as an alternative to the pathological definitive diagnosis.

简介:我们分析了本院的一系列散发性克雅氏病患者:目的:本研究的目的是根据最新公布的标准,使用新的诊断工具来描述样本的特征:我们使用数字化医院登记册进行了一项描述性回顾研究。我们在 2012 年至 2022 年期间发现了 20 例散发性病例:其中 8 例经病理诊断,12 例具有高度可能性。研究记录了性别、发病年龄、演变时间、临床表型、磁共振成像(MRI)结果、14.3.3蛋白、脑电图(EEG)、实时震颤诱导朊病毒蛋白转换(RT-QuIC)、尸检、病理表型和基因诊断等变量:在患者中,50%为男性,50%为女性,发病年龄为67岁(30-83岁),平均存活时间为8个月(1-11个月)。认知障碍是最常见的发病症状,其次是步态共济失调。所有采用长延时序列(FLAIR和DWI)的磁共振成像扫描均为病理扫描,其中以弥漫性皮质和基底节受累最为常见。55%的样本具有特征性三相复合的脑电图。65%的患者脑脊液中14.3.3蛋白呈阳性。进行了四次 RT QuIC 研究(2020 年),结果均为阳性。其中40%进行了确诊尸检,MM/MV1模式最为常见:结论:带有 DWI 序列的磁共振成像是一种特别灵敏的疾病诊断检测方法,但其灵敏度在早期阶段会有所下降。RT-QuIC的特异性和灵敏度都很高,再加上具有特征性的临床诊断和放射学模式,可作为病理确诊的替代方法。
{"title":"[Review of a series of cases of Creutzfeldt-Jakob disease in a tertiary care hospital].","authors":"D Villagrán-Sancho, F J Gómez-Fernández, A C Luque-Ambrosiani, F J Hernández-Chamorro, E Franco-Macías, M Bernal-Sánchez Arjona","doi":"10.33588/rn.7712.2023257","DOIUrl":"10.33588/rn.7712.2023257","url":null,"abstract":"<p><strong>Introduction: </strong>We analysed a series of patients with sporadic Creutzfeldt-Jakob disease in our setting.</p><p><strong>Aim: </strong>The aim of this study is to describe the characteristics of our sample using the new diagnostic tools based on the most recently published criteria.</p><p><strong>Material and methods: </strong>A descriptive, retrospective study was conducted using a digitalised hospital register. We identified 20 cases of the sporadic type, in the period 2012-2022: eight with a pathological diagnosis and 12 with high probability. The variables sex, age at onset, time of evolution, clinical phenotype, magnetic resonance imaging (MRI) findings, 14.3.3 protein, electroencephalogram (EEG), real-time quaking-induced prion protein conversion (RT-QuIC), autopsy, pathological phenotype and genetic diagnosis were recorded.</p><p><strong>Results: </strong>Of those affected, 50% were men and 50%, women, with an age at onset of 67 years (30-83) and a mean survival time of eight months (1-11 months). Cognitive impairment was the most frequent onset symptom, followed by gait ataxia. All MRI scans with long time-lapse sequences (FLAIR and DWI) were pathological, and the pattern of diffuse cortical and basal ganglia involvement was the most frequent. Altogether, 55% of the sample had an EEG with characteristic triphasic complexes. Sixty-five per cent were positive for 14.3.3 protein in cerebrospinal fluid. Four RT QuIC studies were carried out (in 2020) and all were positive. In 40% of them a confirmatory autopsy was performed, with the MM/MV1 pattern being the most frequent.</p><p><strong>Conclusions: </strong>MRI with DWI sequences is a particularly sensitive test for the diagnosis of the disease, although its sensitivity decreases in the early stages. The high specificity and sensitivity of RT-QuIC, together with a characteristic clinical diagnosis and radiological pattern, are proposed as an alternative to the pathological definitive diagnosis.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 12","pages":"299-304"},"PeriodicalIF":0.8,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epilepsy and inequality: demographic description and analysis of the difficulty in accessing advanced resources in a population in a small health area]. [癫痫与不平等:人口统计描述和小卫生领域人口获取先进资源的困难分析]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.33588/rn.7711.2023262
V M Pérez-Navarro, M Cánovas-Iniesta, B Palazón-Cabanes, M Navarro-Lozano

Introduction: Epilepsy is a very common neurological disease with high morbidity and mortality. Drug-resistant epilepsy (DRE) poses a major therapeutic challenge, even for experts in the field. Despite this, access to advanced resources for this type of patient remains difficult and unequal. The aim of this study is to analyse inequality in a population belonging to a first level hospital.

Patients and methods: An analytical observational cross-sectional study was conducted on epileptic patients attending neurology consultations in Area IX of the Murcian Health Service. Demographic, clinical, therapeutic, prognostic and equity variables are described, and significant differences between different subgroups are analysed.

Results: The study included 68 patients with a mean age of 42.93 years. Focal epilepsy was the main type (64.7%), and the most commonly used drugs were levetiracetam (33.8%), valproic acid (27.9%) and lamotrigine (22.1%). DRE occurred in 18 patients (26.5% of the total) and only four were under active follow-up in an epilepsy unit, meaning that 71% did not have access to a necessary resource (advanced therapeutic gap).

Conclusions: This study demonstrates that epilepsy inequality continues to be a problem, especially in certain geographical areas, with a lack of access to advanced care for patients who need it most. The solution can be achieved by increasing human and material resources to improve overall patient care, thus strengthening both referral hospitals and epilepsy units.

癫痫是一种非常常见的神经系统疾病,发病率和死亡率都很高。即使对该领域的专家来说,耐药癫痫(DRE)也是一项重大的治疗挑战。尽管如此,这类患者获得先进资源仍然困难且不平等。本研究的目的是分析属于一级医院的人口中的不平等现象。患者和方法:一项分析性观察性横断面研究对在穆尔西亚卫生服务第九区参加神经内科会诊的癫痫患者进行了研究。描述了人口统计学、临床、治疗、预后和公平性变量,并分析了不同亚组之间的显著差异。结果:纳入68例患者,平均年龄42.93岁。局灶性癫痫为主要类型(64.7%),常用药物为左乙拉西坦(33.8%)、丙戊酸(27.9%)和拉莫三嗪(22.1%)。18名患者(占总数的26.5%)发生了DRE,只有4名患者在癫痫病房接受了积极随访,这意味着71%的患者无法获得必要的资源(先进的治疗差距)。结论:这项研究表明,癫痫不平等仍然是一个问题,特别是在某些地理区域,最需要的患者缺乏获得高级护理的机会。解决办法可以通过增加人力和物力资源来改善病人的整体护理,从而加强转诊医院和癫痫科。
{"title":"[Epilepsy and inequality: demographic description and analysis of the difficulty in accessing advanced resources in a population in a small health area].","authors":"V M Pérez-Navarro, M Cánovas-Iniesta, B Palazón-Cabanes, M Navarro-Lozano","doi":"10.33588/rn.7711.2023262","DOIUrl":"10.33588/rn.7711.2023262","url":null,"abstract":"<p><strong>Introduction: </strong>Epilepsy is a very common neurological disease with high morbidity and mortality. Drug-resistant epilepsy (DRE) poses a major therapeutic challenge, even for experts in the field. Despite this, access to advanced resources for this type of patient remains difficult and unequal. The aim of this study is to analyse inequality in a population belonging to a first level hospital.</p><p><strong>Patients and methods: </strong>An analytical observational cross-sectional study was conducted on epileptic patients attending neurology consultations in Area IX of the Murcian Health Service. Demographic, clinical, therapeutic, prognostic and equity variables are described, and significant differences between different subgroups are analysed.</p><p><strong>Results: </strong>The study included 68 patients with a mean age of 42.93 years. Focal epilepsy was the main type (64.7%), and the most commonly used drugs were levetiracetam (33.8%), valproic acid (27.9%) and lamotrigine (22.1%). DRE occurred in 18 patients (26.5% of the total) and only four were under active follow-up in an epilepsy unit, meaning that 71% did not have access to a necessary resource (advanced therapeutic gap).</p><p><strong>Conclusions: </strong>This study demonstrates that epilepsy inequality continues to be a problem, especially in certain geographical areas, with a lack of access to advanced care for patients who need it most. The solution can be achieved by increasing human and material resources to improve overall patient care, thus strengthening both referral hospitals and epilepsy units.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 11","pages":"259-265"},"PeriodicalIF":0.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138446038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The new age of neurodegenerative diseases. The basis of the new approaches]. 神经退行性疾病的新时代。新方法的基础]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.33588/rn.7711.2023290
G García-Ribas, P Garay-Albizuri, E S Stiauren-Fernández, F Pérez-Trapote, M A Zea-Sevilla

The detection by biomarkers of the pathophysiological and molecular processes involved in misfolding protein diseases making it possible to delineate the natural history of these processes. The great majority of protein misfolding diseases have a prolonged preclinical phase, in which the biological changes are patent. The clinical manifestations (i.e., phenotypes) do not have a univocal correspondence with the underlying pathology, despite the fact that pathological eponyms have been used for the description of the clinical syndromes, which has favored diagnostic inaccuracy. In order to perform an adequate clinical management, we must know the 3 planes that currently define the most common neurodegenerative processes. Diagnostic accuracy will be a prerequisite for new therapies aimed at modifying the course of brain protein misfolding diseases.

通过检测与错误折叠蛋白疾病相关的病理生理和分子过程的生物标志物,使描述这些过程的自然历史成为可能。绝大多数蛋白质错误折叠疾病都有一个延长的临床前阶段,其中生物学变化是专利的。临床表现(即表型)与潜在病理没有明确的对应关系,尽管病理同义词已被用于临床综合征的描述,这有利于诊断的不准确性。为了进行适当的临床治疗,我们必须了解目前定义最常见的神经退行性过程的三个层面。诊断的准确性将是旨在改变脑蛋白错误折叠疾病过程的新疗法的先决条件。
{"title":"[The new age of neurodegenerative diseases. The basis of the new approaches].","authors":"G García-Ribas, P Garay-Albizuri, E S Stiauren-Fernández, F Pérez-Trapote, M A Zea-Sevilla","doi":"10.33588/rn.7711.2023290","DOIUrl":"10.33588/rn.7711.2023290","url":null,"abstract":"<p><p>The detection by biomarkers of the pathophysiological and molecular processes involved in misfolding protein diseases making it possible to delineate the natural history of these processes. The great majority of protein misfolding diseases have a prolonged preclinical phase, in which the biological changes are patent. The clinical manifestations (i.e., phenotypes) do not have a univocal correspondence with the underlying pathology, despite the fact that pathological eponyms have been used for the description of the clinical syndromes, which has favored diagnostic inaccuracy. In order to perform an adequate clinical management, we must know the 3 planes that currently define the most common neurodegenerative processes. Diagnostic accuracy will be a prerequisite for new therapies aimed at modifying the course of brain protein misfolding diseases.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 11","pages":"277-281"},"PeriodicalIF":0.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138446040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neuroanatomical and neuropsychological correlates of shopping addiction behaviour. A systematic review]. 购物成瘾行为的神经解剖学和神经心理学关联。系统回顾]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.33588/rn.7711.2023192
R Martín-Ríos, D Hu-Hai

Introduction: The incidence of compulsive buying has increased over the last two decades and it has a substantial negative impact on consumers' overall functioning. However, despite its clinical relevance, the neuropsychological mechanisms and neural correlates underlying this phenomenon are still unknown. Also, compulsive buying behaviour remains unrecognised as a diagnostic category belonging to addictive disorders.

Aim: The aim of the study is to systematically analyse the available empirical evidence on compulsive buying in order to identify the underlying neuropsychological variables and neural correlates.

Materials and methods: PubMed, Scopus and ScienceDirect were searched for the mechanisms behind this phenomenon.

Results: The results show only 11 recent studies that investigate these mechanisms. In addition, the protocol of this systematic review was pre-registered in the international PROSPERO register (registration number CRD42023427497).

Conclusions: The studies reviewed refer to impaired executive functions, decision-making and sensitivity to rewards, and a tendency to reactivity to purchase-related cues. This pattern of behaviour appears to involve a loss of behavioural control linked to dysregulation of structures such as the striatum and frontal regions. The results obtained are examined and similarities with the mechanisms underlying other addictions are discussed.

引言:强迫性购买的发生率在过去二十年中有所增加,它对消费者的整体功能产生了实质性的负面影响。然而,尽管其临床相关性,神经心理学机制和神经相关的这一现象仍然是未知的。此外,强迫性购买行为仍未被认为是一种属于成瘾性疾病的诊断类别。目的:本研究的目的是系统地分析强迫性购买的现有经验证据,以确定潜在的神经心理学变量和神经相关因素。材料和方法:检索PubMed, Scopus和ScienceDirect以查找这一现象背后的机制。结果:结果显示,最近只有11项研究调查了这些机制。此外,本系统评价的方案在国际PROSPERO注册中进行了预注册(注册号CRD42023427497)。结论:这些研究涉及到执行功能、决策和对奖励的敏感性受损,以及对购买相关线索的反应倾向。这种行为模式似乎涉及与纹状体和额叶区等结构失调有关的行为控制的丧失。所获得的结果进行了检查,并与其他成瘾机制的相似之处进行了讨论。
{"title":"[Neuroanatomical and neuropsychological correlates of shopping addiction behaviour. A systematic review].","authors":"R Martín-Ríos, D Hu-Hai","doi":"10.33588/rn.7711.2023192","DOIUrl":"10.33588/rn.7711.2023192","url":null,"abstract":"<p><strong>Introduction: </strong>The incidence of compulsive buying has increased over the last two decades and it has a substantial negative impact on consumers' overall functioning. However, despite its clinical relevance, the neuropsychological mechanisms and neural correlates underlying this phenomenon are still unknown. Also, compulsive buying behaviour remains unrecognised as a diagnostic category belonging to addictive disorders.</p><p><strong>Aim: </strong>The aim of the study is to systematically analyse the available empirical evidence on compulsive buying in order to identify the underlying neuropsychological variables and neural correlates.</p><p><strong>Materials and methods: </strong>PubMed, Scopus and ScienceDirect were searched for the mechanisms behind this phenomenon.</p><p><strong>Results: </strong>The results show only 11 recent studies that investigate these mechanisms. In addition, the protocol of this systematic review was pre-registered in the international PROSPERO register (registration number CRD42023427497).</p><p><strong>Conclusions: </strong>The studies reviewed refer to impaired executive functions, decision-making and sensitivity to rewards, and a tendency to reactivity to purchase-related cues. This pattern of behaviour appears to involve a loss of behavioural control linked to dysregulation of structures such as the striatum and frontal regions. The results obtained are examined and similarities with the mechanisms underlying other addictions are discussed.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 11","pages":"267-276"},"PeriodicalIF":0.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138446039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Central trochlear nerve palsy treated with inferior oblique muscle weakening]. [下斜肌弱化法治疗中央滑车神经麻痹]。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-12-01 DOI: 10.33588/rn.7711.2023204
E Guzmán-Almagro, E Jarrín-Hernández, M Amosa-Delgado, J González-Martín Moro
{"title":"[Central trochlear nerve palsy treated with inferior oblique muscle weakening].","authors":"E Guzmán-Almagro, E Jarrín-Hernández, M Amosa-Delgado, J González-Martín Moro","doi":"10.33588/rn.7711.2023204","DOIUrl":"10.33588/rn.7711.2023204","url":null,"abstract":"","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 11","pages":"283-284"},"PeriodicalIF":0.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138446037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria. 保加利亚多发性硬化症患者中芬戈莫德的实际疗效。
IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-11-30 DOI: 10.33588/rn.77s04.2023213
I Milanov, S Ivanova, I Tournev, T Chamova, A Kaprelyan, G Slavov, V Chervenkov, K Kipriyanovska

Introduction: Fingolimod, a sphingosine-1-phosphate receptor agonist used for the treatment of multiple sclerosis (MS). Our goal was to assess the impact of fingolimod on quality of life in patients with relapsing-remitting multiple sclerosis (RRMS) after 2 years of treatment in this real-world study.

Patients and methods: This was a 2-year, prospective, observational study conducted in Bulgaria in RRMS patients treated with fingolimod. Quality of life was assessed using the Bulgarian-language version of the MSQoL-54 scale. The primary endpoint was the change from baseline in the MSQoL-54 score after 2 years of treatment. Secondary endpoints included the change from baseline in the MSQoL-54 score after one year of treatment, furthermore the assessment of depression level using the Hamilton D-17 score.

Results: A total of 87 eligible patients were included in the study with a mean age of 38.7 ± 8.45 years. The median Expanded Disability Status Scale (EDSS) score was 3.5 points. We found statistically significant improvement in 10 subscales at month 12 and in seven subscales at month 24. The mental health composite score increased from 64.0 ± 16.69 points to 67.5 ± 15.94 points at month 24 (p = 0.012). The physical health composite score increased from 61.7 ± 17.61 to 66.3 ± 16.70 (p = 0.001). Depression level measured by the HAM-D17 decreased significantly by month 12 and month 24. The EDSS score decreased or remained stable in more than half of the patients (61.6%). We detected better quality of life in patients with a lower EDSS score.

Conclusions: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.

Fingolimod是一种用于治疗多发性硬化症(MS)的鞘氨醇-1-磷酸受体激动剂。我们的目标是评估芬戈莫德对复发-缓解型多发性硬化症(RRMS)患者治疗2年后生活质量的影响。患者和方法:这是一项在保加利亚进行的为期2年的前瞻性观察性研究,研究对象是接受fingolimod治疗的RRMS患者。生活质量采用保加利亚语版本的MSQoL-54量表进行评估。主要终点是治疗2年后MSQoL-54评分与基线的变化。次要终点包括治疗一年后MSQoL-54评分与基线的变化,以及使用Hamilton D-17评分评估抑郁水平。结果:共纳入87例符合条件的患者,平均年龄38.7±8.45岁。扩展残疾状态量表(EDSS)得分中位数为3.5分。我们发现在第12个月有10个分量表改善,在第24个月有7个分量表改善。心理健康综合评分由第24个月的64.0±16.69分上升至第24个月的67.5±15.94分(p = 0.012)。体质健康综合评分由61.7±17.61分提高至66.3±16.70分(p = 0.001)。HAM-D17抑郁水平在第12个月和第24个月显著下降。超过一半的患者(61.6%)的EDSS评分下降或保持稳定。我们发现EDSS评分较低的患者生活质量更好。结论:在现实生活中,芬戈莫德治疗2年以上的RRMS患者的生活质量评分和抑郁水平均有改善。
{"title":"Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria.","authors":"I Milanov, S Ivanova, I Tournev, T Chamova, A Kaprelyan, G Slavov, V Chervenkov, K Kipriyanovska","doi":"10.33588/rn.77s04.2023213","DOIUrl":"10.33588/rn.77s04.2023213","url":null,"abstract":"<p><strong>Introduction: </strong>Fingolimod, a sphingosine-1-phosphate receptor agonist used for the treatment of multiple sclerosis (MS). Our goal was to assess the impact of fingolimod on quality of life in patients with relapsing-remitting multiple sclerosis (RRMS) after 2 years of treatment in this real-world study.</p><p><strong>Patients and methods: </strong>This was a 2-year, prospective, observational study conducted in Bulgaria in RRMS patients treated with fingolimod. Quality of life was assessed using the Bulgarian-language version of the MSQoL-54 scale. The primary endpoint was the change from baseline in the MSQoL-54 score after 2 years of treatment. Secondary endpoints included the change from baseline in the MSQoL-54 score after one year of treatment, furthermore the assessment of depression level using the Hamilton D-17 score.</p><p><strong>Results: </strong>A total of 87 eligible patients were included in the study with a mean age of 38.7 ± 8.45 years. The median Expanded Disability Status Scale (EDSS) score was 3.5 points. We found statistically significant improvement in 10 subscales at month 12 and in seven subscales at month 24. The mental health composite score increased from 64.0 ± 16.69 points to 67.5 ± 15.94 points at month 24 (p = 0.012). The physical health composite score increased from 61.7 ± 17.61 to 66.3 ± 16.70 (p = 0.001). Depression level measured by the HAM-D17 decreased significantly by month 12 and month 24. The EDSS score decreased or remained stable in more than half of the patients (61.6%). We detected better quality of life in patients with a lower EDSS score.</p><p><strong>Conclusions: </strong>Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 s04","pages":"S1-S7"},"PeriodicalIF":0.8,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138452355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bilateral vocal cord paralysis with acute airway obstruction and urgent tracheotomy in a patient with an acute vertebrobasilar stroke]. [双侧声带麻痹伴急性气道阻塞及急性椎基底中风患者的紧急气管切开术]。
IF 1.2 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-11-16 DOI: 10.33588/rn.7710.2023153
C Díaz-Pérez, S Trillo, C Hervás, F Nombela, J Vivancos

Introduction: Vertebrobasilar stroke can be a diagnostic challenge. Bilateral vocal cord paralysis is very rare as a manifestation of acute stroke, yet it is potentially life-threatening because of the possibility of acute airway obstruction. No cases of bilateral vocal cord paralysis have been reported as a presenting symptom of acute stroke of mixed central and peripheral neurological aetiology.

Case report: An 88-year-old woman with dysphonia resulting from paralysis of the right vocal cord following a thyroidectomy presented with sudden onset of vertigo, dysmetria and mild dysarthria (National Institutes of Health Stroke Scale: 2) associated with arterial hypertension. An urgent brain computed tomography (CT) scan evidenced distal occlusive thrombosis of the left vertebral artery without established ischaemia. Due to the improvement of symptoms achieved with control of her blood pressure, revascularisation therapy was not performed. Four hours later, the patient suddenly developed inspiratory stridor and severe respiratory failure due to bilateral vocal cord paralysis with complete airway obstruction. An urgent tracheotomy was performed, which resulted in an improvement in her breathing. A control brain CT scan performed at 24 hours showed established infarction in the left hemicerebellum and lateral medullary region, consistent with the territory of the left posterior inferior cerebellar artery.

Conclusion: Our case illustrates the possibility of the rare occurrence of acute bilateral vocal cord paralysis in the context of acute stroke in conjunction with chronic peripheral involvement of the recurrent laryngeal nerve. Although exceptional, it exemplifies the potential risk associated with vertebrobasilar strokes. A more aggressive reperfusion therapy may be appropriate in these cases, despite an initially mild deficit, because of the possibility of progression to life-threatening complications.

椎基底动脉中风是一个诊断难题。双侧声带麻痹作为急性脑卒中的一种表现是非常罕见的,但它是潜在的威胁生命的,因为它可能导致急性气道阻塞。没有病例双侧声带麻痹的报告,作为一个表现症状的急性中风混合中枢和周围神经病因。病例报告:一名88岁女性,甲状腺切除术后右侧声带瘫痪导致发声障碍,并出现突发性眩晕、韵律障碍和轻度构音障碍(美国国立卫生研究院卒中评分:2),伴有动脉高血压。紧急脑计算机断层扫描(CT)显示远端闭塞血栓左椎动脉没有确定的缺血。由于控制血压后症状有所改善,故未进行血运重建治疗。4小时后,患者因双侧声带麻痹,气道完全阻塞,突然出现吸气性喘鸣及严重呼吸衰竭。进行了紧急气管切开术,使她的呼吸有所改善。24小时后进行的对照脑CT扫描显示,在左小脑和侧髓区建立了梗死,与左小脑后下动脉的范围一致。结论:我们的病例说明了急性脑卒中并发慢性喉返神经外周受累的罕见的急性双侧声带麻痹的可能性。虽然是特例,但它体现了与椎基底动脉中风相关的潜在风险。由于可能发展为危及生命的并发症,在这些病例中,尽管最初有轻微的缺陷,但更积极的再灌注治疗可能是合适的。
{"title":"[Bilateral vocal cord paralysis with acute airway obstruction and urgent tracheotomy in a patient with an acute vertebrobasilar stroke].","authors":"C Díaz-Pérez, S Trillo, C Hervás, F Nombela, J Vivancos","doi":"10.33588/rn.7710.2023153","DOIUrl":"10.33588/rn.7710.2023153","url":null,"abstract":"<p><strong>Introduction: </strong>Vertebrobasilar stroke can be a diagnostic challenge. Bilateral vocal cord paralysis is very rare as a manifestation of acute stroke, yet it is potentially life-threatening because of the possibility of acute airway obstruction. No cases of bilateral vocal cord paralysis have been reported as a presenting symptom of acute stroke of mixed central and peripheral neurological aetiology.</p><p><strong>Case report: </strong>An 88-year-old woman with dysphonia resulting from paralysis of the right vocal cord following a thyroidectomy presented with sudden onset of vertigo, dysmetria and mild dysarthria (National Institutes of Health Stroke Scale: 2) associated with arterial hypertension. An urgent brain computed tomography (CT) scan evidenced distal occlusive thrombosis of the left vertebral artery without established ischaemia. Due to the improvement of symptoms achieved with control of her blood pressure, revascularisation therapy was not performed. Four hours later, the patient suddenly developed inspiratory stridor and severe respiratory failure due to bilateral vocal cord paralysis with complete airway obstruction. An urgent tracheotomy was performed, which resulted in an improvement in her breathing. A control brain CT scan performed at 24 hours showed established infarction in the left hemicerebellum and lateral medullary region, consistent with the territory of the left posterior inferior cerebellar artery.</p><p><strong>Conclusion: </strong>Our case illustrates the possibility of the rare occurrence of acute bilateral vocal cord paralysis in the context of acute stroke in conjunction with chronic peripheral involvement of the recurrent laryngeal nerve. Although exceptional, it exemplifies the potential risk associated with vertebrobasilar strokes. A more aggressive reperfusion therapy may be appropriate in these cases, despite an initially mild deficit, because of the possibility of progression to life-threatening complications.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 10","pages":"253-257"},"PeriodicalIF":1.2,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92156324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Moyamoya in Aragon: epidemiology and self-perception of quality of life]. [烟雾在阿拉贡:流行病学和生活质量的自我感知]。
IF 1.2 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2023-11-16 DOI: 10.33588/rn.7710.2023170
M Bautista-Lacambra, H Tejada-Meza, L F Tique-Rojas, S Vázquez-Sufuentes, M Palacín-Larroy, C Tejero-Juste, J Casado-Pellejero, J Marta-Moreno

Introduction: Moyamoya angiopathy is a vasculopathy caused by stenosis/occlusion of one or both intracranial internal carotid arteries. Although more common in Eastern countries, its prevalence is increasing in the West. An angioresonance or angiography is essential for its diagnosis. There are two options for treatment: conservative (medical) treatment or surgical bypass techniques.

Patients and methods: Nineteen patients were selected using International Classification of Diseases codes, and their demographic characteristics and health outcomes were studied. They were administered a scale for the screening of anxious-depressive syndrome (the Hospital Anxiety and Depression Scale - HADS) and another scale for self-perceived quality of life (SF-36). After applying the inclusion/exclusion criteria, eight of these patients were studied.

Results: Nineteen patients were studied (52.63% male, 57.89% European) and the Aragonese prevalence was estimated at 1.37/100,000 inhabitants. The most frequent clinical presentation was ischaemic stroke (73.68%). The HADS detected two positive cases of anxiety and one case of depression. According to the SF-36, the worst self-rated aspects were vitality (median: 35/100) and general health (median: 42.5/100), while the best rated was physical function (mean: 93.57/100).

Conclusions: This is the Spanish series with the highest prevalence and the only one that addresses self-perceived health and screening of the anxious-depressive syndrome. Further research is needed to address this entity and determine its true prevalence in the West.

烟雾病是一种由一条或两条颅内颈内动脉狭窄/闭塞引起的血管病变。虽然在东方国家更为普遍,但在西方的流行率正在上升。血管磁共振或血管造影对其诊断至关重要。治疗有两种选择:保守(药物)治疗或手术旁路技术。患者和方法:采用国际疾病分类代码选择19例患者,对其人口学特征和健康结局进行研究。他们接受了焦虑抑郁综合征筛查量表(医院焦虑抑郁量表- HADS)和自我感知生活质量量表(SF-36)。应用纳入/排除标准后,对其中8例患者进行研究。结果:19例患者(52.63%为男性,57.89%为欧洲人),阿拉贡人的患病率估计为1.37/100,000。最常见的临床表现为缺血性脑卒中(73.68%)。HADS检测到两个焦虑阳性病例和一个抑郁阳性病例。根据SF-36,自我评价最差的方面是活力(中位数:35/100)和一般健康(中位数:42.5/100),而自我评价最好的方面是身体机能(中位数:93.57/100)。结论:这是西班牙系列中患病率最高的,也是唯一一个关注自我感知健康和焦虑抑郁综合征筛查的系列。需要进一步的研究来解决这一问题,并确定其在西方的真正流行程度。
{"title":"[Moyamoya in Aragon: epidemiology and self-perception of quality of life].","authors":"M Bautista-Lacambra, H Tejada-Meza, L F Tique-Rojas, S Vázquez-Sufuentes, M Palacín-Larroy, C Tejero-Juste, J Casado-Pellejero, J Marta-Moreno","doi":"10.33588/rn.7710.2023170","DOIUrl":"10.33588/rn.7710.2023170","url":null,"abstract":"<p><strong>Introduction: </strong>Moyamoya angiopathy is a vasculopathy caused by stenosis/occlusion of one or both intracranial internal carotid arteries. Although more common in Eastern countries, its prevalence is increasing in the West. An angioresonance or angiography is essential for its diagnosis. There are two options for treatment: conservative (medical) treatment or surgical bypass techniques.</p><p><strong>Patients and methods: </strong>Nineteen patients were selected using International Classification of Diseases codes, and their demographic characteristics and health outcomes were studied. They were administered a scale for the screening of anxious-depressive syndrome (the Hospital Anxiety and Depression Scale - HADS) and another scale for self-perceived quality of life (SF-36). After applying the inclusion/exclusion criteria, eight of these patients were studied.</p><p><strong>Results: </strong>Nineteen patients were studied (52.63% male, 57.89% European) and the Aragonese prevalence was estimated at 1.37/100,000 inhabitants. The most frequent clinical presentation was ischaemic stroke (73.68%). The HADS detected two positive cases of anxiety and one case of depression. According to the SF-36, the worst self-rated aspects were vitality (median: 35/100) and general health (median: 42.5/100), while the best rated was physical function (mean: 93.57/100).</p><p><strong>Conclusions: </strong>This is the Spanish series with the highest prevalence and the only one that addresses self-perceived health and screening of the anxious-depressive syndrome. Further research is needed to address this entity and determine its true prevalence in the West.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 10","pages":"241-248"},"PeriodicalIF":1.2,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92156325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de neurologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1